Trials / Completed
CompletedNCT01384435
A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
A Randomized, Double Blind, Placebo-controlled Phase II Study of KPS-0373 in Patients With SCD
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of KPS-0373 compared to placebo in patients with Spinocerebellar Degeneration (SCD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KPS-0373 | |
| DRUG | KPS-0373 | |
| DRUG | KPS-0373 | |
| DRUG | KPS-0373 | |
| DRUG | Placebo |
Timeline
- First posted
- 2011-06-29
- Last updated
- 2012-12-03
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01384435. Inclusion in this directory is not an endorsement.